6/20/2019  5:31:07 PM Chg. -1.80 Volume Bid5:31:07 PM Ask5:31:07 PM Market Capitalization Dividend Y. P/E Ratio
249.60CHF -0.72% 10,241
Turnover: 2.55 mill.
240.20Bid Size: 10 250.80Ask Size: 340 2.96 bill.CHF 0.84% 41.76

Business description

Tecan Group AG is one of the leading global providers of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also one of the leaders in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.
 

Management board & Supervisory board

CEO
Dr. David Martyr (bis 31.3.2019)
Management board
Dr. Rudolf Eugster, Andreas Wilhelm, Dr. Achim von Leoprechting, Dr. Klaus Lun, Erik Norström, Markus Schmid, Ulrich Kanter
Supervisory board
Dr. Lukas Braunschweiler, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak, Dr. Karen J. Huebscher, Dr. Oliver S. Fetzer, Heinrich Fischer, Lars Holmqvist
 

Company data

Name: Tecan Group AG
Address: Seestrasse 103,CH-8708 Männedorf
Phone: +41-44-922-8111
Fax: +41-44-922-8112
E-mail: info@tecan.com
Internet: www.tecan.com
Industry: Technology
Sector: Other Technology Industries
Sub sector: -
End of financial year: 12/31
Free Float: 45.33%
IPO date: -

Investor relations

Name: Martin Brändle
IR phone: +41-44-922-8430
IR-Fax: +41-44-922-8889
IR e-mail: investor@tecan.com

Company calendar

CW 33 | 8/15/2019 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Freefloat
 
45.33%
Chase Nominees Ltd., London
 
13.10%
NN Groep N.V., Amsterdam (NL)
 
7.20%
Massachusetts Mutual Life Insurance Company - Oppenheimer International Small - Mid Company Fund und OFIGTC International Small Cap Fund - Barings International Small Cap Equity
 
6.31%
UBS Fund Management (Switzerland) AG, Basel (CH)
 
4.90%
BlackRock, Inc.
 
4.90%
APG Asset Management N.V.
 
4.90%
T. Rowe Price Associates
 
2.99%
Credit Suisse Funds AG
 
2.98%
Others
 
7.39%